Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients

The individual risk to progression is unclear for intermediate risk prostate cancer patients. To assess their risk to progression, we examined the level of genomic instability in circulating tumor cells (CTCs) using quantitative three-dimensional (3D) telomere analysis. Data of CTCs from 65 treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Drachenberg, Darrel, Awe, Julius A., Rangel Pozzo, Aline, Saranchuk, Jeff, Mai, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627662/
https://www.ncbi.nlm.nih.gov/pubmed/31226731
http://dx.doi.org/10.3390/cancers11060855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627662/
https://www.ncbi.nlm.nih.gov/pubmed/31226731
http://dx.doi.org/10.3390/cancers11060855

Ejemplares similares